Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.19.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Treasury Stock
Beginning Balance (in shares) at Dec. 31, 2017   87,153,000       3,973,000
Beginning Balance at Dec. 31, 2017 $ 501,875 $ 87 $ 637,851 $ 243 $ (75,046) $ (61,260)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Public offering of common stock, net of $17,056 of offering costs (in shares)   8,050,000        
Public offering of common stock, net of $17,056 of offering costs 441,794 $ 8 441,786      
Issuance of common stock in connection with our acquisitions (in shares)   1,361,000        
Issuance of common stock in connection with our acquisitions 75,150 $ 2 75,148      
Stock option exercises (in shares)   25,000       472,000
Stock option exercises 9,953   4,389     $ 5,564
Issuance of restricted stock (in shares)           1,597,000
Issuance of restricted stock 0   (7,824)     $ 7,824
Treasury stock purchase, at cost (in shares)           660,000
Treasury stock purchased, at cost (22,122)   325     $ (22,447)
Stock-based compensation 38,435   38,435      
Other comprehensive income - derivative instruments (3)     (3)    
Foreign currency translation (33)     (33)    
Net income 28,453          
Ending Balance (in shares) at Sep. 30, 2018   96,589,000       2,564,000
Ending Balance at Sep. 30, 2018 1,075,723 $ 97 1,190,110 207 (44,372) $ (70,319)
Beginning Balance (in shares) at Jun. 30, 2018   96,486,000       2,526,000
Beginning Balance at Jun. 30, 2018 1,039,375 $ 96 1,159,831 253 (53,445) $ (67,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Public offering of common stock, net of $17,056 of offering costs (in shares)   0        
Public offering of common stock, net of $17,056 of offering costs (5) $ 0 (5)      
Issuance of common stock in connection with our acquisitions (in shares)   96,000        
Issuance of common stock in connection with our acquisitions 18,539 $ 1 18,538      
Stock option exercises (in shares)   7,000       105,000
Stock option exercises 2,214   (1,080)     $ 3,294
Issuance of restricted stock (in shares)           64,000
Issuance of restricted stock 0   (1,430)     $ 1,430
Treasury stock purchase, at cost (in shares)           207,000
Treasury stock purchased, at cost (7,362)   321     $ (7,683)
Stock-based compensation 13,935   13,935      
Other comprehensive income - derivative instruments (126)     (126)    
Foreign currency translation 80     80    
Net income 9,073          
Ending Balance (in shares) at Sep. 30, 2018   96,589,000       2,564,000
Ending Balance at Sep. 30, 2018 1,075,723 $ 97 1,190,110 207 (44,372) $ (70,319)
Beginning Balance (in shares) at Dec. 31, 2018   95,991,000       2,341,000
Beginning Balance at Dec. 31, 2018 1,063,024 $ 96 1,187,683 (492) (58,793) $ (65,470)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock in connection with our acquisitions (in shares)   234,000        
Issuance of common stock in connection with our acquisitions 14,846   14,846      
Stock option exercises (in shares)   32,000       200,000
Stock option exercises 4,454   (1,962)     $ 6,416
Issuance of restricted stock (in shares)   7,000       1,331,000
Issuance of restricted stock 499   (40,733)     $ 41,232
Treasury stock purchase, at cost (in shares)           509,000
Treasury stock purchased, at cost (16,771)   2,375     $ (19,146)
Retirement of treasury stock (in shares)   (12,000)       (12,000)
Retirement of treasury stock 0   (152)   (592) $ 744
Stock-based compensation 47,242   47,242      
Other comprehensive income - derivative instruments (2,298)     (2,298)    
Foreign currency translation 277     277    
Net income 38,039       38,039  
Ending Balance (in shares) at Sep. 30, 2019   96,252,000       1,307,000
Ending Balance at Sep. 30, 2019 1,149,312 $ 96 1,209,299 (2,488) (21,371) $ (36,224)
Beginning Balance (in shares) at Jun. 30, 2019   96,152,000       1,292,000
Beginning Balance at Jun. 30, 2019 1,120,319 $ 96 1,189,875 (2,468) (33,075) $ (34,109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock in connection with our acquisitions (in shares)   80,000        
Issuance of common stock in connection with our acquisitions 5,000   5,000      
Stock option exercises (in shares)   13,000       62,000
Stock option exercises 1,385   (685)     $ 2,070
Issuance of restricted stock (in shares)   7,000       63,000
Issuance of restricted stock 499   (1,734)     $ 2,233
Treasury stock purchase, at cost (in shares)           140,000
Treasury stock purchased, at cost (5,663)   755     $ (6,418)
Stock-based compensation 16,088   16,088      
Other comprehensive income - derivative instruments (278)     (278)    
Foreign currency translation 258     258    
Net income 11,704       11,704  
Ending Balance (in shares) at Sep. 30, 2019   96,252,000       1,307,000
Ending Balance at Sep. 30, 2019 $ 1,149,312 $ 96 $ 1,209,299 $ (2,488) $ (21,371) $ (36,224)